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Summary 
Whereas there is considerable information on the phenotypic and functional maturation of T 
cell receptor (TCR) ot/3 thymocytes, comparatively little is known of the maturational processes 
that affect development of TCR-3//8 thymocytes. One class of 3,/8 T cells, those bearing the 
V3'3 gene product, are generated only during the early fetal stages of thymic development, and 
then migrate to the skin. Here we examine the intrathymic differentiation of these V'y3 + cells. 
The earliest V'y3 cells to appear in the thymus expressed low levels of TCR (V3~3  l~  and high 
levels of heat stable antigen (HSA). Over the next few days, V3'3 + thymocytes appeared which 
expressed high levels of TCR  (V3/3hig  h)  and very low levels of HSA.  The antigens  CD5, 
CD45RB, and MEL14 were also differentially expressed on V'y3  l~  versus V3~3high thymocytes, 
but the shift in expression was the opposite as compared with immature and mature TCK-odB 
thymocytes. Transfer experiments of sorted V3,31~  h thymocytes to SCID thymic lobes 
showed  that  these  cells were  indeed  the  precursors  of V3~3high/HSA  l~  thymocytes.  The 
phenotype of the V3/3  high thymocytes was similar to that of the postthymic V'y3 + cells found 
in the skin of adult mice. The differentiation of Vy3  l~  in V3,3hig  h thymocytes was also observed 
in fetal thymic organ culture. Addition of cyclosporin A (CsA) to these cultures had little effect 
on the appearance of V3,31~  h cells, but blocked the appearance of V'y3high/HSA  l~  cells. 
These  results  show  that,  like  c~/3 T  cells, V3,3  +  thymocytes differentiate  from  TCR  l~ 
precursors to cells with a mature phenotype and that CsA inhibits  this  transition. 
T 
he phenotypic changes that are associated with intra- 
thymic differentiation of T cells that express TCR-od3 
are well known (for a review see reference 1). The least ma- 
ture cells are TCK-,  and express low levels of CD5  and 
high levels of heat stable antigen (HSA). They progress into 
CD4 +  CD8 + intermediate cells which express low levels of 
TCK,  and finally into mature CD4 + or CD8 + cells that 
have elevated TCK levels, express high levels of CD5, and 
have lost expression of HSA. During this differentiation, and 
particularly at  the CD4+CD8 + TCK  l~  stage, the func- 
tional repertoire of ot/3 T cells is shaped by both positive 
and negative  selection. 
Comparatively little is known of the developmental stages 
of TCR-3,/8 cells, or of the phenotypic changes that accom- 
pany their maturation.  Several  studies have demonstrated that 
the immunosuppressive drug cyclosporin A (CsA) has little 
or no effect  in vivo or in vitro on the generation of  3'/8 thymo- 
cytes (2-4). Since CsA profoundly blocks the maturation of 
ot/3 thymocytes (2-6), the reported lack of effect on genera- 
tion of the bulk of 3'/8 cells suggests either that these cells 
appear as fully mature cells, or at the very least, that the signals 
required for their maturation are very different from those 
of c~//3 cells. It has also been reported that the level of TCR 
expression on developing "y/8 thymocytes, unlike oe//3 thymo- 
cytes, does not increase during development (7). However, 
more recently, it has been shown that the majority of 3'/8 
cells in the thymus of adult mice express high levels of HSA, 
whereas those in peripheral lymphoid organs fail to express 
this antigen (8). This suggests that immature HSA + cells 
might mature into HSA-  cells. 
A factor that complicates interpretation of the existing data 
with regard to thymic maturation of 31/8 cells is that these 
T cells can be divided into at least two distinct classes based 
on V gene usage, junctional diversity, ontogenic origin, and 
tissue localization (9). Cells that express invariant TCR com- 
posed of V'y3 or V3'4 paired with V81-D81-J82 chains are 
the first T cells to appear during thymic development,  and 
they migrate to the epidermis or the female reproductive epi- 
thelium. Later in thymic development, cells appear that ex- 
press a TCK composed of V3'2 or V'yl paired with a variety 
of V8 products and containing extensive  junctional diversity. 
They comprise the vast majority of 3'/8 T cells in the pe- 
ripheral lymphoid tissues. These two classes of 3'/8 T cells, 
those with invariant and those with variable TCR, may well 
309  J.  Exp. Med.￿9  The Rockefeller University Press ￿9 0022-1007/93/07/0309/07 $2.00 
Volume 178  July 1993  309-315 be subject to different developmental pathways and selective 
pressures. 
In this report, we examine the phenotypic changes that 
accompany thymic development of T  cells that express the 
invariant V3'3/V~l  pair.  We demonstrate that the earliest 
V3'3  cells to appear  in the fetal thymus express low levels 
of TCtL and high levels of HSA. These cells are gradually 
replaced by cells that express  high levels of TCR and are 
HSA  l~  We further show that the same shift in phenotype 
occurs in fetal thymic organ culture (FTOC), and that addi- 
tion of CsA blocks the appearance  of the V~'3hish/HSA  l~ 
population. The phenotype of the descendants of the thymic 
V3'3 cells, the dendritic epidermal cells, is essentially the same 
as that of V3'3hig  h thymocytes. Together, these results sug- 
gest that Vqr  cells undergo a maturational process  in the 
thymus that results in elevation of TCR expression  and loss 
of HSA expression, and that this maturation involves signals 
that are  susceptible  to inhibition by CsA. 
Materials and Methods 
Animals.  BALB/c  and SCID mice, originally purchased from 
Proefdierencentrum  (Catholic University  Leuven,  Leuven,  Belgium) 
and Iffa Credo (L'Arbresle, France), respectively,  were bred in our 
laboratory.  Alternatively, BALB/c mice were purchased from 
Simonsen (Gilroy, CA). To obtain fetal mice, mice were mated for 
15 h and the fetuses were removed at the indicated days of fetal 
development (plug date, day 0). 
Media and Reagents.  IMDM and RPMI-1640 medium sup- 
plemented with t-glutamine and 25 mM Hepes (Gibco Laborato- 
ties, Paisley,  Scotland) were obtained commercially.  Penicillin  (100 
IU/ml), streptomycin (100 #g/ml), 0.03% t-glutamine, and 10% 
heat-inactivated (30 min, 56~  FCS (all products from Gibco 
Laboratories) were added. This medium will be referred to as com- 
plete medium. 
CsA used was the commercially  available Sandimmun (Sandoz, 
Basel, Switzerland). This contains 50 mg/ml CsA in 33% eth- 
anol/67% cremophor. It was diluted in complete medium to ob- 
tain the indicated concentrations of CsA. An equivalent amount 
of the solvent (33% ethanol/67% cremophor) was added to the 
control cultures. 
FTOC.  Thymic lobes were removed from fetuses at day 14 of 
gestation. A FTOC was set up in IMDM complete medium as 
described previously (10) with addition to the culture medium of 
CsA or an equal amount of the solvent (control). After 7 or 12 d, 
a cell suspension was prepared from the thymic lobes by placing 
the lobes in culture medium without FCS and disrupting the tissue 
with a small Potter homogenizer. Cell viability was determined 
by trypan exclusion. 
Transfer  of V73 Thyraocytes  to SCID Thymic Lobes.  Thymocytes 
were prepared from fetal day (FD) 17 BALB/c  embryos and labeled 
with FITC-conjugated anti-V3'3 mAb and with biotin-conjugated 
anti-HSA mAb (second step streptavidin-PE). The cells  were sorted 
on  a  FACS Star Plus  |  (Becton Dickinson  Immunocytometry 
Systems,  Mountain  View, CA)  in  a  V3,3t~  hiss and  a 
V3r3~h/HSAb~ population. A single FD14 SCID thymic lobe was 
placed into each well of a microwell plate (Terasaki, 60  x  10 #1; 
Nunc, Roskilde, Denmark) containing 25/xl of IMDM complete 
medium with 6,500 unsorted FD17 thymocytes,  with 6,500 sorted 
V'y31~  cells or with 3,250 sorted V'y3~sh/HSA  l~  cells. 
From each SCID embryo, one thymic lobe was incubated  with V'y3 
cells as described above, the other lobe was incubated in medium 
alone. The plate was then inverted and cultured for 24 h in a hu- 
midified  petri dish. The lobes were removed  after this period, placed 
onto a filter, and set up as organ cultures and cultured for another 
3 d. Afterwards, a cell suspension  was prepared of  each thymic lobe 
separately, cells  were labeled with FITC-conjugated anti-V3,3 mAb 
and with biotin-conjugated anti-HSA mAb (second step strep- 
tavidin-PE), and analyzed. 
Dendritic Epidermal Cells.  Skin  was removed from killed adult 
BALB/c  mice, digested with trypsin, and epidermal cells were iso- 
lated by Ficoll-Hypaque  density gradient centrifugation (11). Cells 
were cultured overnight in RPMI-1640 complete medium with 100 
U/ml rlL-2 (kindly  provided  by Dr. M. Gately,  Hoffmann-La  Roche, 
Nutley, NJ) to allow reexpression of the TCR that is cleaved off 
by the trypsin treatment. 
Antibodies.  mAb used for staining  were PE and FITC conjugates 
of anti-CD4 and -CD8 purchased from Caltag Laboratories (San 
Francisco, CA) and Becton Dickinson & Co. FITC-conjugated  anti- 
Vy3 (hamster hybridoma F536) (12) and anti-ot/B (hamster hy- 
bridoma H57-597) (13); biotin-conjugated  anti-CD5 (Becton Dick- 
inson & Co.) and anti-CD45RB (hybridoma 16A, rat IgG2a) (14); 
and unlabeled anti-HSA (Jlld,  rat  IgM)  (15) and MEL14 (rat 
IgG2a) (16). 
Flow Cytometric (FCM) Analysis.  Cells  were incubated with 
saturating amounts of antibodies for 1 h at 4~  After washing, 
biotin-conjugated antibodies were revealed  with second step strep- 
tavidin-PE (Becton Dickinson & Co.). Unlabeled antibodies were 
revealed with anti-rat IgG PE (Tago, Inc., Burlingame, CA). 10% 
normal rat serum was added to the samples stained with anti-rat 
Ig PE for all subsequent incubations of  cells with antibodies. Cells 
were analyzed for fluorescence  using a FACScan  |  flow cytometer 
(Becton Dickinson & Co.) with the Lysis  program for data analysis 
as described (Hewlett-Packard  Co., Palo Alto, CA) (10). Propidium 
iodide (Sigma, Deisenhofen, Germany) was added to the cells (2 
/xg/ml) just before FCM analysis.  Gating was done on propidium 
iodide negative cells to exclude the dead cells. 
Results 
Two Populations of V73 Thymocytes: One with a Low, One 
with a High TCR Density.  V3'3 + cells appear in the thymus 
during early fetal development (12) and migrate to the skin 
before birth (17, 18). As a consequence, the differentiation 
from immature to mature V3,3 thymocytes, if present at all, 
has to occur in a limited time period of 3-5 d in the fetal 
thymus. In the TCR-c~/B lineage, differentiating  cells gradu- 
ally upregulate their TCR density. Therefore, we first ana- 
lyzed freshly prepared thymocytes from FD15 to FD18 em- 
bryos for the density of the TCR on the V3'3 cells. From 
the results (Fig.  1), it is clear that the major part of TCK- 
V3'3 thymocytes at FD15 had a low TCR density. At FD16, 
some Vy3 cells expressed the TCtL at a higher level. At FD17 
and FD18, two populations of V3'3 thymocytes could be rec- 
ognized: one with a low, and one with a high density of 
the TCR (these two populations will be further referred to 
as V3,3  l~  and V3,3his  h, respectively).  These results suggest 
that V3,3  l~  thymocytes differentiate to V3,3his  h cells. 
Phenotypic Analysis of V73 ~  and V73hi~  * Thymocytes.  As 
in the TCR-oJ~ lineage (19), also in the TCR-3,/6 lineage 
HSA has been suggested to be a marker of immature, func- 
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Figure  1.  TCR density on developing V3'3 thymocytes.  Freshly pre- 
pared thymocytes from FD15 to FD18 embryos were labeled with FITC- 
labeled anti-V3,3 mAb. Propidium iodide was added  just before FCM anal- 
),sis. Fluorescence histograms are shown for propidium iodide negative cells. 
tionally incompetent cells, whereas HSA-  cells are mature 
and functionally competent (8,  20).  The results of double 
color fluorescence analysis show that the major part of the 
V~/31~  cells were bright for HSA staining, whereas V3'3hig  h 
cells were mainly HSA low (Fig.  2).  In addition, we ana- 
lyzed expression of other surface antigens that have been de- 
scribed to be differentially expressed on immature and ma- 
ture TCR-ol//3 thymocytes. For comparison, adult thymocytes 
were stained with anti-TCR-cff/3 mAb in combination with 
the same antibodies. With regard to V3'3  thymocytes, ex- 
pression of the antigens CD5 and MEL14 was downregu- 
lated, whereas CD45RB was upregulated. The shift in ex- 
pression  of  these  antigens  on  differentiating  TCIL-c~//~ 
thymocytes was the opposite.  Other markers that are differen- 
tially expressed on immature and mature TCR-cx/B thymo- 
cytes, namely CD2,  CD28,  and CD69,  showed no differ- 
ence in  expression between the two  populations  of V'y3 
thymocytes (data not shown). At no time during fetal devel- 
opment did more than  15%  of V'y3 + thymocytes express 
CD4 or CD8, (data not shown). This low level expression 
of CD4 and CD8 was observed on both the V3/3 + popula- 
tions. Thus, it appears  that V3,3 + thymocytes do not pass 
through a CD4+CD8 + double position stage.  From these 
data, we conclude that (a) two populations of TCR-V3,3 cells 
are present in the thymus: one with an immature and one 
with a mature phenotype; and that (b) some phenotypic char- 
acteristics of this maturation are different from those in TCR- 
o~//~ thymocytes. 
Vy31~  high Thymocytes Are the Precursors of V'y31~igh/ 
HSA h~ ThymocTtes.  To determine whether V3,31~  h 
thymocytes are the precursors of V')'3high/HSA l~  thymo- 
cytes, we sorted these two populations from FD17 thymo- 
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Figure 2.  Phenotypic differences between the 
two populations of V3'3 thymocytes. Freshly pre- 
pared thymocytes from FD15  to FD18  embryos 
were colabeled with anti-V~/3 mAb and with sev- 
eral other antibodies as indicated. In paralld, adult 
thymocytes were labeled with anti-c~/B mAb plus 
the same antibodies. Propidium iodide was added 
just before FCM analysis. Fluorescence dot plots 
are shown for propidium iodide negative cells, The 
HSA expression was obtained by labding the cells 
with J11d anti-HSA mAb, but the same results were 
obtained with B2A2 and M1/69 anti-HSA mAb 
(data not shown). TRANSFERRED  FD17  THYMOCYTES 
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Figure 3.  Transfer  of sorted V3'3 
thymocytes to SCID thymic lobes. 
FD17  BALB/c  thymocytes  were 
colabeled with FITC-labeled anti- 
V3'3  mAb and with biotinylated 
anti-HSA mAb (second step strep- 
tavidin-PE). V3,3J~  h and 
V'),3hish/HSA  ~~  cells were sorted. 
FD14SCID thymic lobes were in- 
cubated in  a  hanging  drop with 
medium alone, with 6,500 unsorted 
FD17 thymocytes, with 6,500 sorted 
V731~  h  cells,  or  with 
3,250 sorted V3,3hish/HSA  jow cells 
for  1 d.  Lobes  were cultured  in 
FTOC for an additional 3 d. Cell 
suspensions were prepared from each 
lobe separately  and they were hbeled 
with FITC-labeled anti-V3,3 mAb 
and  with  biotinyhted  anti-HSA 
mAb (second step streptavidin-PE). 
(~p)  Dot  plots of unsorted  and 
sorted populations of FD17 BALB/c 
thymocytes.  The numbers are the 
percentages of V~/31~  h and 
vy3high/HSA I~  cells. (Bottom) Dot 
plots of SCID lobes after FTOC. 
Numbers  are  the  cell  numbers 
per  lobe of V')'31~  h and 
V'y3high/HSA  l~  cells.  Propidium 
iodide was added just before FCM 
analysis. Dot plots are shown for 
propidium iodide negative cells. The 
results shown are representative for 
two experiments. 
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Figure 4.  Phenotypic analysis 
of  skin-located  V3~3  +  T  cells 
from adult mice. Epidermal cells 
were prepared from the skin of 
adult  mice  and  were  colabeled 
with anti-V3'3 and with several 
other antibodies as indicated. Pro- 
pidium iodide was added  just be- 
fore FCM analysis. Dot plots are 
shown for propidium iodide nega- 
tive cells. 
upper panel of Fig. 3 shows the FACS  |  analysis of unsorted 
FD17 thymocytes and of the two sorted populations.  The 
lower panel of Fig. 3 shows the FACS |  analysis of the SCID 
thymic lobes 3 d after transfer of these thymocyte popula- 
tions. No V3'3 cells could be detected in SCID thymic lobes 
cultured in medium alone. A low number of both vy3high/ 
HSA  l~  and  V3'31~  high cells  was  clearly  present  in 
lobes that were incubated in a hanging drop with 6,500 un- 
sorted FD17 thymocytes. These unsorted thymocytes were 
also labeled with anti-Vy3 mAb and with anti-HSA mAb 
before the transfer.  3 d after transfer of sorted V3r31~  - 
high cells,  a high  number of VT3hish/HSA l~  cells could be 
recovered from the lobes. The main contaminating  cells in 
the sorted population were V3'3-  cells. These cells can not 
account for the generation of V3'3high/HSA l~  cells as only a 
low number of these cells  is detected after transfer  of un- 
sorted thymocytes (98% of these cells are V3'3-).  The ap- 
pearance  of V3'3~gh/HSA  l~  cells in SCID thymic lobes after 
transfer  of sorted V3,31~  hish cells could also not be due 
to contamination of these sorted cells with V3r3high/HSA  ~~ 
cells. First of all, only few, if any, V3,3high/HSA  l~  cells were 
present in the sorted V3dl~  h population.  In addi- 
tion, these few contaminating cells cannot explain the high 
number of V3/3high/HSA t~  cells after culture. Transfer  of a 
high  number of sorted V'y3high/HSA l~  cells  only yields a 
low number of these cells after culture. From other experi- 
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to V3,31~  high cells,  die within  12 h when cultured in 
cell suspension (data not shown). Thus, the V'y3~gh/HSA  l~ 
cells may perish in the hanging drop culture or fail to enter 
the thymic lobe. This transfer experiment  directly demon- 
strates  that  V3,31~  HSA  high thymocytes  are  indeed  the 
precursors  of V3'3high/HSN  ~  thymocytes. 
The Phenotype of Skin-derived V9~3 T Cells Is Similar to that 
of Vy3hig  h Thymocytes.  Since we have previously demon- 
strated  that  V3,3 +  fetal  thymocytes  are  the  precursors  of 
V3~3 + T  cells  in  the epidermis  (17),  we also performed  a 
phenotypic analysis of these cells. As shown in Fig. 4, these 
cells are negative for HSA and CD5, positive for CD45RB, 
and mainly negative for MEL14. Thus, the phenotype of the 
epidermal  Vy3 §  T  cells  is essentially the  same as that  of 
V'y3hig  h thymocytes. 
CxA Blocks Differentiation  of Vy3 Thymocytes.  As CsA has 
been described to block the development of c~/~ thymocytes, 
we examined its effect on differentiation of V3~3 thymocytes. 
Pregnant mice were injected with CsA to study its effect on 
embryonic thymic development. However, as was frequently 
observed, this  treatment  caused growth retardation  of the 
embryos, and sometimes even resulted in their death. For these 
reasons,  experiments  were done in FTOC.  The results are 
shown in Table 1.  It is shown,  as described earlier,  that  1 
/~g/ml CsA blocked development of single CD4 thymocytes. 
Concerning  the effect on V3r3 thymocytes, CsA treatment 
had little effect on the cell number of immature V3'3 cells. 
However, generation of mature V3'3 cells was largely inhibited. 
These results  show that  maturation  from V3,31~  h 
to V'y3h~gh/HSA  l~  thymocytes involves signals that can be 
inhibited  by CsA. 
Table  1.  Effect of CsA on 1f"73 Maturation 
CsA concentration 
Cells/lobe  Control  0.16  0.4  1  2.5 
~g/ml 
Total  225,000  127,000  100,000  70,000  45,000 
CD4 §  22,500  5,080  2,810  3,460  2,100 
CD4+CD8 *  112,500  36,410  33,010  24,400  10,520 
CD4-CD8-  49,500  56,410  39,150  27,470  24,190 
CD8 §  40,500  29,100  25,030  14,670  8,190 
V'y31~  3,820  4,190  4,200  4,410  2,200 
V'y3high/HSA  l~  4,950  3,420  1,700  560  360 
FD14 thymic lobes  were cultured in a FTOC with the indicated concen- 
trations of CsA. After 12 d, cell suspensions were prepared and the per- 
centages of the different subpopuhtions  were determined by FCM analysis. 
Data are expressed as the total cell number per lobe or the call number 
per lobe for each subpopulation. 
Discussion 
We have shown that  the first TCR-V3,3 cells to appear 
in the fetal thymus are V3,3 l~  cells and that they are gradu- 
ally replaced by V~/3~  h cells. This upregulation of the TCR 
on 3///~ cells during thymic differentiation has not been pre- 
viously discussed. We demonstrate that V3,3 l~  thymocytes 
express high levels of HSA, whereas V3'3  ~gh cells are HSAbw, 
suggesting that V3,3  l~  cells are immature cells, V3,3h~g  h cells 
are mature. Although this phenotypic change of differentiating 
V3,3 thymocytes mimics the change associated with matura- 
tion of TC1L-ct/~ thymocytes, there are clearly differences 
for other phenotypic characteristics of the maturation of TCR- 
V3r3 versus TCR-r  thymocytes. We directly demonstrate 
that  V731~  h  thymocytes  are  the  precursors  of 
Vqf3~h/HSAl~  thymocytes and that the phenotype of these 
latter cells is essentially the same as that of their descendants 
in the skin,  showing that  indeed a maturational  process is 
occurring. This is supported by the fact that CsA blocks the 
shift  from  V'y31~  to  V'y3high/HSA l~  cells  in 
FTOC. 
Our CsA data are in contrast to previous reports that con- 
cluded that CsA did not affect the generation of 3~//~ T cells 
(2-4).  However, these studies dealt only with the effect of 
CsA on the yield of the total 3~/~ population,  and did not 
examine the effects on maturation of particular 'y/~ subsets. 
Our conclusion is that at least one class of 3r/6 T cells, those 
found in the adult skin and expressing an invariant V3,3/V~1 
TCR, undergoes maturation in the early fetal thymus, and 
that  this maturation  is susceptible to inhibition  by CsA. 
The maturation of V3,3 thymocytes is phenotypically similar 
to the maturation of c~/3 thymocytes in that it is accompa- 
nied by an increase in levels of expression of the TCR and 
loss of expression of HSA. Antibodies against CD5, CD45RB, 
and MEL14 differentially stained the V3,3 l~  and the V~/3  high 
population,  but the shift in expression was the opposite as 
compared with o~/3 thymocytes. We can only speculate on 
the reason for this, but it may reflect differences in function 
of mature c~/3 and 3'/6 T  cells,  rather  than  differences in 
maturational  mechanisms.  MEL14 is a homing receptor for 
lymphocytes migrating  to peripheral lymph node high en- 
dothelial venules (16). V3'3 thymocytes migrate to the skin 
(17, 18), and a homing receptor has not been described. The 
ligand for CD5 has recently been described to be the B cell 
surface  protein  CD72  (21).  It  was  suggested  that  the 
CD5-CD72 interaction  is important in activation and prolifer- 
ation of T cells by antigen-presenting B lymphocytes. Since 
skin-located V3~3 T cells recognize antigens expressed on ke- 
ratinocytes but not B cells (22), CD5 interactions  may not 
be important for the function of mature V'y3 calls, but rather 
may play a role in their early thymic differentiation. Another 
phenotypical difference between development of ot/B thymo- 
cytes and V3~3 thymocytes is  their  CD4-CD8  expression. 
Whereas  the  majority  of c~//3 thymocytes are  CD4-CD8 
double positive at an intermediate stage in their intrathymic 
differentiation,  we  could  never  detect  more  than  15% 
CD4 +  CD8 + double positive V'y3 thymocytes, in either the 
V"/31~  high  population,  or  in  the  V'y3high/HSA l~ 
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cently described by Fisher  et al.  (23). 
It is well accepted that maturation of ot//~ thymocytes in- 
volves rescue by positive selection of clones expressing a TCK 
with the potential for recognition of foreign peptides in the 
context of self-MHC gene products. Thus, for ot/~ cells, en- 
gagement of the TCK during positive selection has two effects: 
shaping  of the repertoire by selection of particular  TCKs, 
and stimulation  of maturation  of immature  cells by TCK- 
mediated signal transduction.  Whether both these processes 
occur during maturation of 3'//i thymocytes is not clear. Posi- 
tive selection on class I MHC is not required for all 3'/~ cells, 
since the distribution and function of most 3'/~ cells, including 
the V3'3 cells  in the epidermis,  is normal  in/~2-microglo- 
bulin-deficient  mice (8, 24, 25).  It has been demonstrated 
that  class  I MHC expression is necessary for development 
of 3'5 cells in mice transgenic for a class I MHC-specific TCR 
of the variable type, utilizing V3'2 (20, 26). However, in no 
instance has an allele-specific  requirement  for MHC prod- 
ucts been demonstrated.  Concerning the invariant V3'3 and 
V3'4 T cells of the skin and reproductive epithelium, as well 
as their precursors in the fetal thymus,  identical junctional 
sequences are  found in MHC-disparate  mice (27,  28).  Al- 
though data have been reported that seem to support a role 
for positive selection in shaping the TCK repertoire ofinvar- 
iant 3'/~ T cells (29), other data fail to support this conclu- 
sion (9). Two recent reports provide strong support for the 
notion that the invariant repertoire is largely shaped intracel- 
lularly by the recombinase machinery rather than by cellular 
selection (30, 31). In mice unable to express cell surface 3'/5 
TCK because of disruption  of the C/~ gene,  the frequency 
of canonical Vqr3 and V3'4 rearrangements was no different 
than in control mice (30). Similarly,  canonical Vqr3 and V~4 
rearrangements in transgenic  mice bearing recombination sub- 
strates containing termination codons were found at frequen- 
cies similar to those of the endogenous genes (31). Since in 
neither case was the product expressed at the cell surface, cel- 
lular selection is effectively excluded as a major force in shaping 
the repertoire. 
Our  results  clearly demonstrate  that  V3'3 + thymocytes 
undergo a phenotypic maturation, and that there is a require- 
ment for CsA-sensitive signals,  most likely generated by the 
TCK, in this maturation.  This process is highly reminiscent 
of positive selection in or//3 T  cell development.  However, 
since the TCK repertoire of the Vy3 + cells  appears  to be 
determined by intracellular mechanisms, TCl~-mediated sig- 
naling in these cells may serve merely to test the developing 
thymocytes for successful surface expression of a TCK whose 
composition and junctional sequence have been predetermined, 
and ensure the survival and maturation  of these cells.  This 
dual requirement for a stem cell-directed rearrangement  process 
checked by a receptor-mediated signal could explain the ob- 
servation  that  both  fetal  stem  cells  and  the  fetal  thymic 
microenvironment  are required for the generation of Vy3 § 
T  cells  (32,  33). 
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